Mimedx Group, Inc. MDXG

What this company does

MIMEDX provides a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. It sources donated birth tissue, namely the human placental membrane, umbilical cord and the placental disc, through a donor network with hospitals and clinician groups. The donated tissue is shipped to its manufacturing facilities in Marietta, Georgia, where it undergoes testing followed by a proprietary tissue manufacturing workflow the company calls the PURION process. MIMEDX has supplied several million allografts, filling direct orders and consignment orders, through December 31, 2025. As of December 31, 2025, the company had 808 full-time employees. For the years ended December 31, 2025, 2024 and 2023, its top ten customers accounted for 22%, 20% and 20%, respectively, of net sales. MIMEDX has secured payer coverage for over 300 million covered lives.

Written from the business description in MIMEDX GROUP, INC.'s annual report to the U.S. Securities and Exchange Commission, filed 25 February 2026. Every sentence was checked against that document before publication.